HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome

Home   |   Publication   |   HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome
Publications
75 +
Clinical Trials Ran
0 +
Approved Therapies
0

Areas of Expertise